Two Sigma Advisers’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History

Two Sigma Advisers’s Portfolio STSA Stock Details STSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-274,000	Closed	-$191K	–	2752
2023 Q1	$191K	Buy	274,000 +121,700	+80%	+$112K	﹤0.01%	2278
2022 Q4	$137K	Buy	152,300 +117,500	+338%	+$340K	﹤0.01%	2253
2022 Q3	$209K	Sell	34,800 -2,800	-7%	-$15.9K	﹤0.01%	2186
2022 Q2	$156K	Sell	37,600 -29,000	-44%	-$102K	﹤0.01%	2324
2022 Q1	$253K	Sell	66,600 -21,400	-24%	-$96.4K	﹤0.01%	2302
2021 Q4	$396K	Sell	88,000 -47,300	-35%	-$240K	﹤0.01%	2029
2021 Q3	$630K	Sell	135,300 -47,200	-26%	-$250K	﹤0.01%	1829
2021 Q2	$1.29M	Sell	182,500 -39,700	-18%	-$214K	﹤0.01%	1518
2021 Q1	$1.31M	Buy	222,200 +29,500	+15%	+$179K	﹤0.01%	1498
2020 Q4	$888K	Sell	192,700 -24,300	-11%	-$105K	﹤0.01%	1616
2020 Q3	$844K	Buy	+217,000	New	+$4.36M	﹤0.01%	1576

Two Sigma Advisers's STSA Position: Q2 2023 in Review

Two Sigma Advisers sold out of Satsuma Pharmaceuticals, Inc. Common Stock (STSA) in Q2 2023, closing a stake of 274,000 shares — an estimated $191K sold.

Two Sigma Advisers first reported a position in STSA in Q3 2020 and held it in 11 quarters. The position peaked at $1.31M in Q1 2021. 0 funds tracked by Wall St. Rank hold STSA as of Q2 2023.

Two Sigma Advisers reported no remaining Satsuma Pharmaceuticals, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Two Sigma Advisers sold 274,000 Satsuma Pharmaceuticals, Inc. Common Stock shares in Q2 2023, an estimated $191K.
Two Sigma Advisers first reported a position in Satsuma Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 11 quarters.
Two Sigma Advisers's Satsuma Pharmaceuticals, Inc. Common Stock position peaked at $1.31M in Q1 2021.
0 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals, Inc. Common Stock as of Q2 2023.

Based on Two Sigma Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.